
==== Front
Hypertens Res
Hypertens Res
Hypertension Research
0916-9636
1348-4214
Springer Nature Singapore Singapore

39039283
1769
10.1038/s41440-024-01769-6
Article
Vasopressin and cardiovascular autonomic adjustment in chronic hypertensive pregnancy
Jovanović Mirjana 1
Stevanović Bojana 2
Pajović Vladislav 3
Tasić Tatjana 2
Lozić Maja 3
Đukić Ljiljana 2
Kosić Marija 3
Murphy David 4
Japundžić-Žigon Nina nina.japundzic@gmail.com

3
1 https://ror.org/0285t0292 0000 0004 0388 7268 Department of Pathophysiology, University of Belgrade Faculty of Medicine, Belgrade, RS Serbia
2 https://ror.org/03jjdcp59 University of Belgrade Faculty of Dentistry, Belgrade, RS Serbia
3 https://ror.org/0285t0292 0000 0004 0388 7268 Department of Pharmacology, University of Belgrade Faculty of Medicine, Belgrade, RS Serbia
4 https://ror.org/0524sp257 grid.5337.2 0000 0004 1936 7603 Bristol Medical School: Translational Health Sciences, University of Bristol, Bristol, UK
22 7 2024
22 7 2024
2024
47 9 23932404
27 2 2024
24 5 2024
6 6 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Chronic hypertensive pregnancy (CHP) is a growing health issue with unknown etiology. Vasopressin (VP), a nonapeptide synthesized in paraventricular (PVN) and supraoptic nucleus (SON), is a well-known neuroendocrine and autonomic modulator of the cardiovascular system, related to hypertension development. We quantified gene expression of VP and its receptors, V1aR and V1bR, within the PVN and SON in CHP and normal pregnancy, and assessed levels of secreted plasma VP. Also, we evaluated autonomic cardiovascular adaptations to CHP using spectral indices of blood pressure (BPV) and heart rate (HRV) short-term variability, and spontaneous baroreflex sensitivity (BRS). Experiments were performed in female spontaneously hypertensive rats (SHRs) and in normotensive Wistar rats (WRs). Animals were equipped with a radiotelemetry probe for continuous hemodynamic recordings before and during pregnancy. BPV, HRV and BRS were assessed using spectral analysis and the sequence method, respectively. Plasma VP was determined by ELISA whilst VP, V1aR, and V1bR gene expression was analyzed by real-time-quantitative PCR (RT-qPCR). The results show that non-pregnant SHRs exhibit greater VP, V1aR, and V1bR gene expression in both PVN and SON respectively, compared to Wistar dams. Pregnancy decreased VP gene expression in the SON of SHRs but increased it in the PVN and SON of WRs. Pregnant SHRs exhibited a marked drop in plasma VP concentration associated with BP normalization. This triggered marked tachycardia, heart rate variability increase, and BRS increase in pregnant SHRs. It follows that regardless of BP normalization in late pregnancy, SHRs exhibit cardiovascular vulnerability and compensate by recruiting vagal mechanisms.

Pregnant SHR dams have reduced expression of VP in SON associated with increased V1bR expression, lower plasma VP, normal BP during late pregnancy and marked signs of enhanced sympathetic cardiac stimulation (increased HR and LFHR variability) and recruitment of vagal mechanisms (enhancement of BRS and HFHR variability).

Keywords

Autonomic cardiovascular control
Chronic hypertensive pregnancy
Vasopressin
Paraventricular nucleus
Supraoptic nucleus
issue-copyright-statement© The Japanese Society of Hypertension 2024
==== Body
pmcIntroduction

Chronic hypertensive pregnancy (CHP) is defined as the rise of systolic blood pressure (SBP) >140 mmHg and/or diastolic blood pressure (DBP) >90 mmHg, observed before the 20th week of gestation [1]. It is estimated that CHP is present in 0.9–1.5% of pregnant women. A further growth in the number of pregnant individuals with CHP is expected due to increasing obesity rate and trends towards and upward shift in the conception age [1, 2].

In CHP, both foetal and maternal complications are increased and may be very serious, including placental abruption, peripartum hemorrhage, cerebrovascular accident, pulmonary edema, and acute kidney injury [2, 3]. Also, later in life, mothers have an increased incidence of cardiovascular, metabolic, and cerebrovascular diseases [1, 3].

In pregnancy, the mother exhibits numerous physiological changes. Most of these modifications start in early pregnancy and are maintained throughout the whole period of gravidity in order to provide enough blood and oxygen supply for the developing foetus, guaranteeing the positive pregnancy outcome [4]. Cardiovascular adaptation to normotensive pregnancy includes vasodilation followed by a decrease in total peripheral resistance and the consequent decrease in arterial blood pressure (BP) and an increase in heart rate (HR) and cardiac output due to enhanced sympathetic outflow. Systemic and renal vasodilation is accomplished by increasing vasodilator synthesis [5, 6] and by reducing vascular sensitivity to vasoconstrictors [7], both of which oppose compensatory sympathetic hyperactivity [8, 9]. In normal pregnancy, increased maternal plasma volume leads to relative hyponatremia and anemia [7, 10]. The expanded circulating blood volume in pregnancy is due to the resetting of the osmotic threshold for vasopressin secretion [11, 12]. Yet, the neuroendocrine and autonomic adaptation of the cardiovascular system to hypertensive pregnancy is insufficiently understood.

It is well established that neurohypophyseal peptide oxytocin plays a key role in neuroendocrine adaptation to healthy normal pregnancy, delivery, and lactation. However, the impact of vasopressin (VP) in the same physiological context is not fully understood. VP and oxytocin are synthesized in magnocellular neurons of supraoptic nucleus (SON) and paraventricular (PVN). They both act as neurohormones and neurotransmitters to modulate the cardiovascular system. Magnocellular neurons in SON and PVN release VP into the circulation where it regulates blood volume and BP. At the same time, parvocellular VP-synthesizing neurons of the PVN project to the rostral part of the medulla (RVLM) where sympathetic outflow to the cardiovascular system is set, as well as to the intermediolateral column of the spinal cord (IML) where the bodies of sympathetic ganglionic neurons are located. From both projections, VP neurons can modulate autonomic control of the cardiovascular system [13–16]. Under baseline physiological conditions, gamma-aminobutyric acid (GABA) containing neurons surrounding the PVN tonically inhibit excitatory glutamate inputs to pre-sympathetic neurons. During stress or pathological dysregulation magnocellular neurons (MCNs) and parvocellular neurons (PCNs) are activated to a different degree by being disinhibited or stimulated by glutamate [17, 18].

In a well-recognized animal model of genetic hypertension—Spontaneously hypertensive rats (SHR) [19, 20] and human hypertensives [21] VP has been shown to play an important pathophysiological role and contribute to the severity of the disease [13, 14]. We thus hypothesized that neuroendocrine adaptation to pregnancy by VP differs in hypertensive and normal pregnancy. Our aim was to quantify gene expression of VP, and its V1aR and V1bR receptors within the PVN and SON in SHRs and control Wistar rats (WR) dams. These data were compared with VP secretion, and with autonomic cardiovascular adaptations to pregnancy in normotensive and hypertensive animals using spectral indices of cardiovascular variability and spontaneous baroreflex sensitivity (BRS).

Materials and methods

The experimental protocol was approved by the School of Medicine University of Belgrade Ethic Committee review board and The Ministry of Agriculture, Forestry and Water Economy of the Republic of Serbia (license n°119–01–13/17/2015–09). All experimental procedures in this study conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes, as well as the U.K. Animals Act, 1986, and ARRIVE guidelines, National Act on Animal Welfare 2009/6/RS, and Rule book 2010/RS.

Animals

Experiments were performed on 12 weeks old female WR (N = 22) and SHR (N = 22) rats (185–250 g) bred at a local animal facility, housed individually in controlled environment (12 h/12 h light dark-cycle, lights on at 7:00 a.m., temperature 21 ± 2 °C and humidity 60 ± 5% [v/v]) with free access to standard pelleted chow (0.2% sodium content, Veterinarski zavod, Subotica) and tap water. Before all experimental procedures, the animals were allowed a 2 week long adjustment period for acclimation to the new environment and animal handling, including sampling of vaginal smears. At the end of the experiment, all rats were euthanized by decapitation.

Surgical implantation of radio telemetry devices

Virgin female WRs (N = 6) and SHRs (N = 6) were anaesthetized by combined ketamine (90 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) anesthesia. After preoperative trichotomy and disinfection of the abdominal area with hydrogen peroxide and povidone-iodine, a 3 cm-long ventral midline incision was made and the intestines were retracted. A catheter tip of the radiotelemetric probe (TA11-PA C40; DSI, Transoma Medical, St Paul, MN, USA) was inserted into the exposed aorta, fixed with 3M VetbondTM and tissue cellulose patch (DSI, Transoma Medical). The body of radiotelemetric probe was placed in the abdominal cavity and attached to the anterior abdominal wall. The surgical incision was closed by two layers of non-absorbable sutures. Postoperative treatment was provided by cleaning the sutured incision with hydrogen peroxide and povidone-iodine. Gentamicin (25 mg/kg, i.m.) was given preoperatively and for the following three days to prevent infection. For pain management, rats received carprofen (5 mg/kg/day, s.c.) on the day of the surgery and for the following two days. The recovery period lasted for 2 weeks including body weight and the estrus cycle [22].

Determination of the estrous cycle and pregnancy

In order to determine the estrous cycle female rats, Wistar and SHR, were examined daily, approximately for 1 month (2 weeks prior to the surgical implantation procedure, during recovery period and data acquisition). A plastic pipette tip (prefilled with 10 μL 0.9% [w/v] NaCl) was inserted into the atrium of their vagina to collect fluid, a drop of which was placed on glass slides to be observed unstained under a light microscope with magnification lenses 10× and 40×. Three types of cells can be recognized in unstained vaginal smear: epithelial round-shaped cells with nucleus, cornified cells of irregular shape without nucleus, and leukocytes, the smallest round cells. The proportion of these cells in the smear was used to determine the phases of the estrous cycle. According to Marcondes et al. [23, 24], proestrus smear consists of a predominance of epithelial cells; an estrous smear consists of a predominance of cornified cells; while a metestrus smear has the same proportion of leukocytes, cornified, and epithelial cells. Diestrus smear consists of a predominance of leukocytes. At diestrus, female rats were recorded for basal physiological values of cardiovascular hemodynamic parameters before pregnancy. On the night of proestrus, a single virgin female equipped with a transmitter device was housed with a sexually experienced male rat of the same strain. In order to achieve a pregnancy, in the morning, after the couple was caged together, a vaginal smear was re-examined and the presence of spermatozoa or vaginal plug was considered Day 0 of gestation. The average gestation time for WRs is 21 days, while for SHRs is 22 days (data from our local Animal facility).

Experiment design

SHR and WR females, equipped with TA-11-PAC40 devices were subjected to continuous measurement of cardiovascular hemodynamics. Data acquisition was performed before pregnancy—diestrus, in the middle and late pregnancy (gestational day 20/21). After decapitation, truncal blood and the brain were collected for further analysis.

BP and HR acquisition and cardiovascular variability analysis

Arterial blood pressure signals were continuously transferred from the radio-telemetry device implanted in rat’s aorta and placed in the intra-abdominal cavity of rats to a computer equipped with Dataquest A.R.T.4.0. software (DSI, Transoma Medical, St. Paul, USA) specialized in the acquisition and analysis of cardiovascular signals. Arterial BP was recorded at 1000 Hz sampling frequency, then resampled at 20 Hz in a Dataquest A.R.T.4.0. software. Systolic pressure, diastolic pressure, and pulse interval or its inverse value (HR) were derived from arterial pulse waves as maximum, minimum, and inter-beats interval, respectively. After the manual withdrawal of artefacts, 410s-long stationary segments were chosen for power spectrum analysis on 30 overlapped 2048-point time series [25, 26]. Power spectra were analyzed in total (TV: 0.00976–3 Hz), very-low-frequency (VLF: 0.00976–0.195 Hz), low-frequency (LF: 0.195–0.8 Hz) and high-frequency (HF:0,8–3 Hz) range. LF-BP and LF/HF-HR are recognized markers of sympathetic outflow to arterial blood vessels and sympatho-vagal balance to the heart in both experimental [27, 28] and clinical practices [25, 26].

BRR evaluation by sequence method

The spontaneous baroreceptor reflex sequence is a stream of consecutively increasing/decreasing SBP samples, followed by a stream of increasing/decreasing pulse interval samples delayed by 3, 4, or 5 beats regarding SBP. A threshold for sequence length was set to four beats. The sensitivity of baro-receptor reflex [ms/mmHg] was assessed as a linear regression coefficient averaged over all identified sequences, baro-receptor reflex sensitivity (BRS) = (pulse interval-const)/(systolic blood pressure) [29]. A more refined method for this dependency analysis is proposed in Jovanovic et al. [30].

Tissue and blood collection

Additional four groups of females, diestrus WRs (N = 8) and diestrus SHR (N = 8), and late pregnant WRs (N = 8) and SHRs (N = 8), previously time-mated in our research facility, were euthanized by decapitation (Rat guillotine, Harvard Apparatus, Holliston, MA, USA). The brains were harvested, frozen in liquid nitrogen, and stored at −80 °C for PVN and SON sampling. The blood samples were taken according to the manufacturer’s instructions and stored at −80 °C for VP plasma estimation.

Evaluation of mRNA expression of VP, V1aR and V1bR in the rat PVN and SON

By using a cryostat (Leica Microsystems CM1900, Leica Microsystems, Nussloch GmbH, Nussloch, Germany), 60 μm thick caudal-rostral brain slices were taken and stained with Toluidine blue (1% [w/v] in 70% [v/v] ethanol, Sigma-Aldrich Co. Ltd, Poole, Dorset, UK) for mapping and verification of the hypothalamus. Both bilateral SON and PVN, unstained tissue was punched, taking 1 mm in diameter, using a 15-G Sample Corer (Fine Science Tools Inc., Foster City, CA, USA, cat.no 18035-01), and stored in RNase-free tubes (ISOLAB Laborgeräte GmbH, Eschau, Germany) at −80 °C.

RNA extraction, cDNA synthesis, and real time quantitative polymerase chain reaction (qPCR) and data analysis

Total RNA was extracted from samples by TRIzol reagent (Life Technologies, Carlsbad, USA), chloroform (Sigma-Aldrich, Taufkirchen, Germany), and 2-propanol (Sigma-Aldrich, Taufkirchen, Germany). RNA quality and yield were assessed by using BioSpec-nano (Shimadzu, Kyoto, Japan). Thus, cDNA was synthesized by QuantiTect Reverse Transcription Kit (Qiagen, Hilden, Germany) according to the manufacturer´s instructions. RT-qPCR was obtained in Applied Biosystems ViiaTM 7 (Foster City, CA, USA). All assays were performed in triplicates, using 96-well reaction plates (Foster City, CA, USA). The reaction volume contained: 1 µL cDNA sample, 0.048 µL 100 nM primers (Invitrogen, Pacle, UK), 6 µL Power SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK), and 4.9 µL RNase-free water (Qiagen, Hilden, Germany). The Primer Express software (version 3.0.1, Thermo Fisher Scientific, Foster City, CA, USA) and GenBank database were used to design specific primers for: vasopressin gene (forward: 5′-GCA CCC ATC AGC CTA ATT CG-3′; reverse: 5′-CGC CAA CCT ATT ATG CCC TAG TA-3′), V1aR (Rn Avpr1a 1 SG QuantiTect Primer Assay, QT00402990, NM053019), V1bR (forward: 5′-TGCCACATTCCTGGAGTACCT-3′; reverse: 5′-AGGACGGTTAACCAAGTAG TGAGATG-3′) and Rpl19 gene (forward: 5′-GCG TCT GCA GCC ATG-3′; reverse: 5′-TGG CAT TGG CGA TTT-3′) as a house-keeping gene. The applied RT-qPCR reaction was composed of cDNA denaturation (50 °C–2 min, 95 °C–10 min), 40 cycles of cDNA amplification (95 °C–10 min, 60 °C–1 min), and melting curves analysis (95 °C–15 s, 60 °C–1 min, 95 °C–15 s). Relative gene expression was estimated by the 2-ΔΔCt method [31].

Determination of VP plasma level

Truncal blood samples were collected in sterile plastic tubes using ethylenediaminetetraacetic acid as an anticoagulant. The samples were centrifuged for 15 min at 1000 × g at 4 °C within 30 min of collection. The obtained plasma samples were then aliquoted in sterile plastic tubes and kept at −80 °C until analysis. Vasopressin plasma levels were quantified by enzyme-linked immunosorbent assay (ELISA) method using Rat ADH (Antidiuretic Hormone) ELISA Kit (Elabscience Biotechnology Inc., USA) with a sensitivity of 9.38 pg/ml. The assay was performed according to the manufacturer’s instructions. The optical density was determined using a microplate reader set to 450 nm (Multiskan EX, Thermo Electron Corporation, Vantaa, Finland). Vasopressin plasma levels were expressed in pg/ml.

Statistical analysis

Data are represented as median, minimum, and maximum values. Data were analyzed using IBM SPSS software (SPSS Statistics v.20 software IBM Corporation, NY, USA). Data distribution was examined using the Kolmogorov–Smirnov test. For each experimental group, cardiovascular parameters collected over time, on diestrus, in middle and late pregnancy were evaluated by the Independent Friedman test. Data are represented as median, minimum and maximum values. qPCR data and VP plasma level data were analyzed by the Kruskal–Wallis test (followed by the Wilcoxon test). Statistical significance was considered at p < 0.05.

Results

VP and VP receptor gene expression in the PVN and the SON of non-pregnant and pregnant rats

Before pregnancy, SHR females showed elevated VP and V1a gene expression in the PVN compared to WR counterparts, and their levels persisted throughout gestation. In late pregnancy, VP and V1a receptor gene expression in the PVN increased in WRs in respect to diestrus, becoming comparable to SHR. V1bR mRNA levels were not statistically different between strains before or during pregnancy (Fig. 1).Fig. 1 VP and VP receptors gene expression in the PVN of diestrus and late pregnant WRs and SHRs. SHRs exhibit upregulation of VP and V1aR mRNAs in diestrus and are maintained until the end of pregnancy. A notable increase of VP and V1aR mRNA expression can be observed in the PVN of late-pregnant WRs. Blue boxes: WR female rats; red boxes: SHR female rats; DE diestrus; LP late pregnancy. Data were analysed using Kruskal–Wallis followed by Mann–Whitney U statistical tests and significance was *p < 0.05 vs diestrus; ††p < 0.05 vs WR

In the SON of non-pregnant SHR, VP mRNA and V1b mRNA were increased in respect to non-pregnant WRs. Pregnancy differentially affected VP expression in strains: VP gene expression was increased in WRs and decreased in SHRs. The expression of V1bR was not altered by pregnancy in both strains (Fig. 2).Fig. 2 VP and VP receptors gene expression in the SON of diestrus and late pregnant WRs and SHRs. A marked pregnancy-induced increase of VP can be noted in the WR group. On the contrary, pregnancy decreased the initially higher gene expression of VP in SON of SHRs. V1bR mRNA was elevated and remained elevated in pregnancy in SHR compared to WRs. Blue boxes: WR female rats; red boxes: SHR female rats; DE diestrus; LP late pregnancy. Kruskal–Wallis followed by Mann–Whitney test was performed with significance **p < 0.01 vs diestrus; †p < 0.05 vs WR; ††p < 0.05 vs WR

Plasma VP levels in non-pregnant and pregnant rats

Plasma VP concentrations were the same in both strains before pregnancy. In both normotensive and hypertensive females, pregnancy reduced plasma VP levels, with a more prominent drop in late pregnant SHRs (Fig. 3).Fig. 3 Plasma VP of diestrus and late pregnant WRs and SHRs. A marked diminution of plasma VP levels induced by pregnancy was seen in both experimental groups, with a more profound change in SHRs at the end of the pregnancy. Blue boxes: WR female rats; red boxes: SHR female rats; DE diestrus; LP late pregnancy. The data were estimated by Kruskall–Wallis test and Mann–Whitney statistical test; **p < 0.01 vs diestrus; ††p < 0.05 vs WR

Cardiovascular hemodynamics and spectral markers in non-pregnant and pregnant rats

Regardless of the different starting points of SBP and DBP in non-pregnant WRs and SHRs over the course, pregnancy decreased both SBP and DBP. The decrease of SBP and DBP was pronounced in SHR and reached normal normotensive values in late pregnancy. The reduction of SBP and DBP was followed by a reduction of total SBP and DBP variability. The spectral analysis also revealed an increase of HF SBP domain in pregnant WRs (Fig. 4).Fig. 4 SBP and DBP short-term variability in WR and SHR rats. Pregnancy triggers a marked decrease of SBP and DBP in both groups, with total BP variability downfall in respective groups. Also, late-pregnant WRs demonstrated an increase of HF SBP. Blue lines: WR female rats; red lines: SHR female rats; DE diestrus; MD mid-pregnancy; LP late pregnancy. Data were analysed using the independent Friedman test and significance was *p < 0.05 over time; **p < 0.01 over time; †p < 0.05 late pregnancy vs diestrus baseline; ††p < 0.01 late pregnancy vs diestrus baseline

HR increased in both strains at the end of pregnancy (Fig. 5). In SHR and WRs, LF-HR also increased. This increase was greater in SHR denoting marked sympathetic cardiac stimulation. However, in SHR and WRs a marker of sympathovagal balance LF/HF-HR remained unchanged. This was due to a concomitant increase of vagally mediated HF-HR. (Fig. 5).Fig. 5 HR and HR short-term variability in WR and SHR rats. Note the increase of HR throughout the course of pregnancy in both strains. SHRs exhibit marked uprise in LF and HF-HR band, without significant change in LF/HF ratio. Blue lines: WR female rats; red lines: SHR female rats; DE diestrus; MD mid-pregnancy; LP late pregnancy. The data were estimated by independent Friedman test; *p < 0.05 over time; †p < 0.05 late pregnancy vs diestrus baseline; #p < 0.05 late pregnancy vs middle pregnancy

Baroreceptor reflex sensitivity in non-pregnant and pregnant rats

The baroreceptor reflex sensitivity did not change in WRs over the course of pregnancy. However, in SHR dams, BRS increased significantly in late pregnancy with respect to diestrus SHR values and pregnant WRs (Fig. 6).Fig. 6 BRS in WR and SHR rats. SHRs exhibit a rise in BRS as the pregnancy approaches late stage. Blue lines: WR female rats; red lines: SHR female rats; DE diestrus; MD mid-pregnancy; LP late pregnancy. The independent Friedman test was performed for data regarding BRS; *p < 0.05 over time; †p < 0.05 late pregnancy vs diestrus baseline

Discussion

This study shows, for the first time, that whilst pregnancy increases VP gene expression in the PVN and SON of normotensive WR, it decreases in the SON of pregnant SHRs resulting in a considerable drop in plasma VP concentration. In SHR rats before and throughout pregnancy V1aR and V1bR are over-expressed in PVN and SON respectively, while in Wistar dams the expression of V1aR in PVN increases only in late pregnancy. PVN V1aRs expressed on PCNs, can be activated by intranuclearly released VP and enhance sympathetic outflow to the heart [32], as observed in both pregnant WRs and SHRs. Also, V1aR and V1bR on MCNs have been shown to orchestrate VP release [33]. It seems that in SON V1bR outweighs autocontrol management of VP synthesis in MCNs [34].

The drop of plasma VP was associated with BP normalization in SHR in late pregnancy, recruitment of baroreflex mechanism leading to marked tachycardia, and LF-HR variability uncovering cardiovascular vulnerability of pregnant SHR regardless of BP normalization.

It is thought that VP is involved in the etiology of hypertension [35]. In this context, both the hormonal and neurotransmitter functions of VP are considered to contribute to the development of this condition [13, 36, 37]. SHRs and hypertensive humans have elevated plasma VP levels and increased vasculature sensitivity to exogenously applied VP, corroborating with the severity of clinical presentation [36, 38]. Brain VP content in the stroke-prone variety of SHRs is upregulated in PVN and SON with the progression of hypertension [39]. We have also shown that Borderline hypertensive rats have greater basal expression of VP in the PVN, inherited from their hypertensive parent (SHR mothers) [40]. According to available research data, VP plasma content of SHRs should correlatively increase with the progression of hypertension. A detectable rise in circulatory VP can be observed starting from the 24th week of age (six months old) in SHRs, whilst in the prior period, VP circulatory levels are the same in normotensive and hypertensive rats [41]. This is in line with our finding of similar VP plasma levels in 3-month-old SHR and WR dams during diestrus. Our results support the concept of heightened VP system activity in the hypothalamus of SHR females before pregnancy. SHR dams have increased VP gene expression within the PVN and SON in the diestrus phase with respect to WRs, possibly as a result if increased VP gene transcription.

An interesting finding is that pregnant SH rats exhibited a marked decrease of VP gene expression in the SON and a marked decrease in plasma VP concentrations. A similar finding was reported in women where the decrease of VP in pregnancy is ascribed to increased clearance by placental peptidases [42]. However, the placenta of pregnant rats do not apparently synthesize vasopressinase [43], so in the present study, the decrease of plasma VP in pregnancy is rather due to reduced release of VP into plasma rather than increased plasma clearance. In this context, it is important to mention that hypoosmolality during pregnancy does not affect VP release as it would be expected, due to the resetting of MCNs [11, 42]. Surprisingly, VP does not seem to be the underlying mechanism for AQP2 over-expression in renal collecting ducts and pregnancy-induced water overload [44]. A possible culprit for the retained VP secretion into circulation observed in our data could be relaxin. It has been shown in gravid Sprague Dawley rats that VP release is relaxin mediate [45]. The same study reports basally lower VP plasma levels in 21-day pregnant rats compared to non-pregnant animals. Also, the effects of relaxin-orchestrated VP secretion seem to wither overtime, and are attenuated in the late pregnancy stage, supporting the minimal VP plasma at the end of the pregnancy measured in our experiments [45]. The decrease of plasma VP concentration could contribute to the decrease in BP by lack of the stimulation of V1aR in smooth muscle cells which contribute to overall peripheral resistance and thus BP level.

Apart from being secreted into the circulation to act as a hormone, VP is also being released from axons of PCNs (pre-autonomic neurons located in the parvocellular part of the PVN) into the RVLM and IML of the spinal cord where presympathetic neurons and preganglionic sympathetic neurons are located to increase sympathetic outflow to the cardiovascular system [15]. Almost a quarter of these parvocellular projecting neurons synthesise VP [46] and V1aRs are abundantly expressed in both RVLM and IML [47, 48]. Under basal physiological conditions, NO tonically inhibits neuronal activity in hypothalamic magnocellular and pre-autonomic neurons mainly due to presynaptic facilitation of GABA-ergic neurotransmission [49–51]. In hypertension, glutamatergic activation of the PVN in the SHR drives elevated basal sympathetic activity [52]. In addition, in normal pregnancy, NO production in PVN is decreased and PVN neurons are disinhibited enhancing sympathetic outflow to the periphery [53]. Our findings corroborate the view of increased sympathetic activity to the heart of pregnant Wistar damns, and, strikingly to the hearts of SHR pregnant dams, as denoted by increased HR and LF-HR spectral parameters.

An increase of vasopressin V1aR in PVN and V1bR mRNAs in SON of SHR dams needs further elaboration. Wistar pregnant rats manifest increased expression of V1aR and VP in SON in late pregnancy. V1aR and V1bR were found in abundance on MCNs [33, 40, 54] to exert autocrine control on the somatodendritic release of VP. Somatodendritic release of VP orchestrates the firing rates of MCNs to stimuli, such as blood osmotic status, volume, and pressure to best fit the physiological demands [55]. The spillover of somatodendritically released VP within the PVN is proven to excite spinally projecting parvocellular neurons by activation of V1aR residing on their membrane, resulting in coordinated neuroendocrine and sympathetic response to homeostatic challenges [32]. A somatodendritic discharge of VP is separately regulated from the plasma VP release and it may occur singly [56]. The content of vesicles carrying VP intended for a somatodendritic release differs from the ones destined for axonal transport, and are enriched with galanin [57]. There is no clear view on VP receptor expression in PVN during pregnancy, and only few studies referred to this issue. It seems that the V1aR distribution is rather stable, with most dynamic changes occurring in postpartum and during lactation. Nevertheless, it has been shown that V1aR is upregulated in the PVN of prairie voles in late pregnancy stages, indicating maternal priming of the PVN for V1aR-mediated sensitivity to VP [58, 59]. Our results coincide with this finding and report elevated V1aR mRNA levels along with increased VP expression, of both strains in late pregnancy. We can speculate that V1aR located on PCNs that project to the RVLM and IML could act to increase sympathetic outflow to the heart as a response to generalized vasodilation in late pregnancy in both strains. However, during late pregnancy in the SON of SHR, the expression and release of VP was reduced while V1bR expression remained increased in respect to WR. Lately, it has been suggested that V1bR might be mainly responsible for the VP autoregulation of magnocellular neurons in SON, providing a short-loop feedback mechanism that affects VP synthesis locally [34, 60]. Our results indicate recruitment of these autocrine mechanisms on MCNs in SHR mitigating negative feedback on VP synthesis to counteract markedly reduced VP blood levels. Autocrine roles of VP receptors on VP synthesis in MCNs probably underlies differences between strains in late pregnancy. For instance, V1bR over-expression in the SON of SHR decreases VP mRNA expression while the lack of it in WR enhances it. Also V1aR over-expression in the PVN of WR in late pregnancy may be the cause of boosted VP expression in WR which annuls species differences in VP synthesis in late pregnancy.

As expected, late pregnancy reduced SBP and DBP and their variabilities, followed by reflex increase of HR in both strains. These findings are in agreement with the results of previously conducted studies in animals [61, 62]. Apart from the well-described vasodilation and compensatory sympathetic increase, these hemodynamic data might be justified in correlation with the VP plasma decrease observed during pregnancy in our animals. However, a more noticeable drop in BP was observed in SHR pregnant females, corresponding to even lower VP values measured in the plasma of hypertensive animals, which is no surprise since VP is a potent pressor agent [36].

According to our results, the reduction in BP and BP TV observed in both WRs and SHRs occurs mainly due to a decrease in VLF-BP range and can be explained by over-expression and synthesis of AT2R in blood vessels of pregnant rats which mediate vasodilation [63], decrease in plasma VP, increased synthesis of vasodilating molecules [5, 6] and blood vessels indifference to vasoconstrictors [7]. Interestingly, LF-BP variability tended to decrease and did not reflect increased sympathetic tone directed to blood vessels due to vascular indifference to noradrenaline. Normotensive pregnancy is usually stated as only ‘healthy’ physiological conditions of basal sympathetic hyperactivity [8]. However, pregnancy is also characterized by impaired neurovascular transduction [62, 64], meaning blood vessels are unresponsive to sympathetic stimulation, supporting a sustainable decrease in total peripheral resistance [65–67]. Of note is that WRs displayed an increase of HF SBP with the gestational progress, described previously by others [61]. The HF zone of SBP variability may be elevated by profound vasodilatation [68] or by changes in breathing patterns [69]. Since WR dams in our experiments did not exhibit any change in the respiratory rate advocated by HF position in BP and HR spectra, change in HF SBP can be attributed to pregnancy-induced vasodilatation and consequent thoracic blood vessels under-filling.

Cardiac indices of increased sympathetic stimulation during late pregnancy were obvious in both strains and documented by increased HR and LF-HR variability bands, and were especially marked in SHR dams. At the same time, SHR dams had increased vagally mediated HF-HR variability. The increase of vagal influences to the heart is reported to be useful in protecting the heart against sympathetic overstimulation, involving cholinergic NO synthesis in ventricles, and may improve cardiac health issues [70]. Altogether, increased LF-HR and HF-HR along with no change in LF/HF index, suggest that both autonomic limbs are co-active at the same time and lead to efficient cardiac function in pregnant SHRs [71]. Perhaps the increase in vagal tone to the heart could be mediated by centrally acting vasopressin and the stimulation of V1aR in the medulla [72]. An increase in BRS in SHR in late pregnancy also denotes enhanced vagal drive to the heart. Only a few papers have considered autonomic adjustment of cardiovascular control in CHP with contradictory reports. Some report a decrease in arterial blood pressure accompanied by unchanged BRS in pregnant SHR [62], reduced BRS [73], or increased BRS [74] in chronic hypertensive women [73]. Enhanced parasympathetic cardiac modulation in SHRs was also reported to be improved [62].

It would be of interest to evaluate and compare the effects of antihypertensive drugs on plasma VP, BRS, and HRV as well as associated risks for mother and child in CHP. One of the reasons why non/treated subjects with CHP, even though with normalized blood pressure, are prone to hypertensive crisis, maybe due to sympathetic overstimulation that overcomes protective vasodilative mechanisms associated with pregnancy. Also, hypervolemia predisposed to blood pressure increase. Therefore, strong vasodilators are necessary to prevent/treat hypertensive crises. According to revised ACOG guidance (2019) based on the CHAP trial [75] treatment of mild CHP is recommended as well as tight control of BP in severe cases.

In conclusion, our results show that pregnant SHR dams have reduced expression of VP in SON associated with increased V1bR expression, lower plasma VP, and normal BP during late pregnancy. They also show marked signs of enhanced sympathetic cardiac stimulation (increased HR and LF-HR variability) and recruitment of vagal mechanisms (enhancement of BRS and HF-HR variability) to defend against it.

Acknowledgements

This work was supported by the Ministry of Science, Technological Development and Innovation of Serbia (grant number: 200110, MJ, BS, VP, MK, TT, ML, NJŽ), British Heart Foundation (RG/11/28714, DM; FS/12/5/29339 DM) and BBSRC (BB/J005452/1, DM).

Author contributions

All authors contributed to the design, performance, analysis, reporting, and writing of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 203: chronic hypertension in pregnancy Obstet Gynecol 2019 133 e26 50 10.1097/AOG.0000000000003020 30575676
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–50.30575676 10.1097/AOG.0000000000003020
2. Seely EW Ecker J Chronic hypertension in pregnancy Circulation 2014 129 1254 61 10.1161/CIRCULATIONAHA.113.003904 24637432
Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129:1254–61.24637432 10.1161/CIRCULATIONAHA.113.003904
3. Chandrasekaran S Badell ML Jamieson DJ Management of chronic hypertension during pregnancy JAMA 2022 327 1700 1 10.1001/jama.2022.3919 35503360
Chandrasekaran S, Badell ML, Jamieson DJ. Management of chronic hypertension during pregnancy. JAMA. 2022;327:1700–1.35503360 10.1001/jama.2022.3919
4. Gd TKBS. Maternal adaptations to pregnancy. In: Knobil ENJD, editor. The physiology of reproduction. 3rd ed. New York: Raven Press; 2006. p. 2899–923.
5. Osol G Ko NL Mandalà M Plasticity of the maternal vasculature during pregnancy Annu Rev Physiol 2019 81 89 111 10.1146/annurev-physiol-020518-114435 30742784
Osol G, Ko NL, Mandalà M. Plasticity of the maternal vasculature during pregnancy. Annu Rev Physiol. 2019;81:89–111.30742784 10.1146/annurev-physiol-020518-114435
6. Leo CH Jelinic M Ng HH Marshall SA Novak J Tare M Vascular actions of relaxin: nitric oxide and beyond Br J Pharm 2017 174 1002 14 10.1111/bph.13614
Leo CH, Jelinic M, Ng HH, Marshall SA, Novak J, Tare M, et al. Vascular actions of relaxin: nitric oxide and beyond. Br J Pharm. 2017;174:1002–14.10.1111/bph.13614
7. Tkachenko O Shchekochikhin D Schrier RW Hormones and hemodynamics in pregnancy Int J Endocrinol Metab 2014 12 e14098 10.5812/ijem.14098 24803942
Tkachenko O, Shchekochikhin D, Schrier RW. Hormones and hemodynamics in pregnancy. Int J Endocrinol Metab. 2014;12:e14098.24803942 10.5812/ijem.14098
8. Jarvis SS Shibata S Bivens TB Okada Y Casey BM Levine BD Sympathetic activation during early pregnancy in humans J Physiol 2012 590 3535 43 10.1113/jphysiol.2012.228262 22687610
Jarvis SS, Shibata S, Bivens TB, Okada Y, Casey BM, Levine BD, et al. Sympathetic activation during early pregnancy in humans. J Physiol. 2012;590:3535–43.22687610 10.1113/jphysiol.2012.228262
9. Cohen WR Galen LH Vega-Rich M Young JB Cardiac sympathetic activity during rat pregnancy Metabolism 1988 37 771 7 10.1016/0026-0495(88)90013-3 3405094
Cohen WR, Galen LH, Vega-Rich M, Young JB. Cardiac sympathetic activity during rat pregnancy. Metabolism. 1988;37:771–7.3405094 10.1016/0026-0495(88)90013-3
10. Sanghavi M Rutherford JD Cardiovascular physiology of pregnancy Circulation 2014 130 1003 8 10.1161/CIRCULATIONAHA.114.009029 25223771
Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003–8.25223771 10.1161/CIRCULATIONAHA.114.009029
11. Durr JA Stamoutsos B Lindheimer MD Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation J Clin Invest 1981 68 337 46 10.1172/JCI110261 7263858
Durr JA, Stamoutsos B, Lindheimer MD. Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation. J Clin Invest. 1981;68:337–46.7263858 10.1172/JCI110261
12. Davison JM Gilmore EA Dürr J Robertson GL Lindheimer MD Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy Am J Physiol 1984 246 F105 9 6696073
Davison JM, Gilmore EA, Dürr J, Robertson GL, Lindheimer MD. Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy. Am J Physiol. 1984;246:F105–9.6696073
13. Japundžić-Žigon N Lozić M Šarenac O Murphy D Vasopressin & oxytocin in control of the cardiovascular system: an updated review Curr Neuropharmacol 2020 18 14 33 10.2174/1570159X17666190717150501 31544693
Japundžić-Žigon N, Lozić M, Šarenac O, Murphy D. Vasopressin & oxytocin in control of the cardiovascular system: an updated review. Curr Neuropharmacol. 2020;18:14–33.31544693 10.2174/1570159X17666190717150501
14. Japundžić-Žigon N Vasopressin and oxytocin in control of the cardiovascular system Curr Neuropharmacol 2013 11 218 30 10.2174/1570159X11311020008 23997756
Japundžić-Žigon N. Vasopressin and oxytocin in control of the cardiovascular system. Curr Neuropharmacol. 2013;11:218–30.23997756 10.2174/1570159X11311020008
15. Savić B Murphy D Japundžić-Žigon N The paraventricular nucleus of the hypothalamus in control of blood pressure and blood pressure variability Front Physiol 2022 13 858941 10.3389/fphys.2022.858941 35370790
Savić B, Murphy D, Japundžić-Žigon N. The paraventricular nucleus of the hypothalamus in control of blood pressure and blood pressure variability. Front Physiol. 2022;13:858941.35370790 10.3389/fphys.2022.858941
16. Savić B López SB Murphy D Japundžić-Žigon N Central neuroendocrine control of the cardiovascular system Masterclass in Neuroendocrinology 2023 Cham Springer International Publishing 17 42
Savić B, López SB, Murphy D, Japundžić-Žigon N. Central neuroendocrine control of the cardiovascular system. Masterclass in Neuroendocrinology. Cham: Springer International Publishing; 2023. p. 17–42.
17. Li YF Jackson KL Stern JE Rabeler B Patel KP Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus Am J Physiol Heart Circ Physiol 2006 291 H2847 56 10.1152/ajpheart.00625.2005 16877560
Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP. Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus. Am J Physiol Heart Circ Physiol. 2006;291:H2847–56.16877560 10.1152/ajpheart.00625.2005
18. Li YF Mayhan WG Patel KP NMDA-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide Am J Physiol Heart Circ Physiol 2001 281 H2328 36 10.1152/ajpheart.2001.281.6.H2328 11709399
Li YF, Mayhan WG, Patel KP. NMDA-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. Am J Physiol Heart Circ Physiol. 2001;281:H2328–36.11709399 10.1152/ajpheart.2001.281.6.H2328
19. Lerman LO Kurtz TW Touyz RM Ellison DH Chade AR Crowley SD Animal models of hypertension: a scientific statement from the American Heart Association Hypertension 2019 73 e87 120 10.1161/HYP.0000000000000090 30866654
Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, Crowley SD, et al. Animal models of hypertension: a scientific statement from the American Heart Association. Hypertension. 2019;73:e87–120.30866654 10.1161/HYP.0000000000000090
20. Reckelhoff JF Romero DG Yanes Cardozo LL Sex, oxidative stress, and hypertension: insights from animal models Physiology 2019 34 178 88 10.1152/physiol.00035.2018 30968750
Reckelhoff JF, Romero DG, Yanes Cardozo LL. Sex, oxidative stress, and hypertension: insights from animal models. Physiology. 2019;34:178–88.30968750 10.1152/physiol.00035.2018
21. Morton JJ Padfield PL Vasopressin and hypertension in man J Cardiovasc Pharm 1986 8 S101 6 10.1097/00005344-198600087-00020
Morton JJ, Padfield PL. Vasopressin and hypertension in man. J Cardiovasc Pharm. 1986;8:S101–6.10.1097/00005344-198600087-00020
22. Takezawa H Hayashi H Sano H Saito H Ebihara S Circadian and estrous cycle-dependent variations in blood pressure and heart rate in female rats Am J Physiol 1994 267 R1250 6 7977852
Takezawa H, Hayashi H, Sano H, Saito H, Ebihara S. Circadian and estrous cycle-dependent variations in blood pressure and heart rate in female rats. Am J Physiol. 1994;267:R1250–6.7977852
23. Marcondes FK Bianchi FJ Tanno AP Determination of the estrous cycle phases of rats: some helpful considerations Braz J Biol 2002 62 609 14 10.1590/S1519-69842002000400008 12659010
Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 2002;62:609–14.12659010 10.1590/S1519-69842002000400008
24. Goldman JM Murr AS Cooper RL The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies Birth Defects Res B Dev Reprod Toxicol 2007 80 84 97 10.1002/bdrb.20106 17342777
Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 2007;80:84–97.17342777 10.1002/bdrb.20106
25. Parati G Ulian L Santucciu C Omboni S Mancia G Blood pressure variability, cardiovascular risk and antihypertensive treatment J Hypertens Suppl 1995 13 S27 34 10.1097/00004872-199512002-00005 8824684
Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens Suppl. 1995;13:S27–34.8824684 10.1097/00004872-199512002-00005
26. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Eur Heart J 1996 17 354 81 8737210
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354–81.8737210
27. Tasić T Djordjević DM De Luka SR Trbovich AM Japundžić-Žigon N Static magnetic field reduces blood pressure short-term variability and enhances baro-receptor reflex sensitivity in spontaneously hypertensive rats Int J Radiat Biol 2017 93 527 34 10.1080/09553002.2017.1276307 28051886
Tasić T, Djordjević DM, De Luka SR, Trbovich AM, Japundžić-Žigon N. Static magnetic field reduces blood pressure short-term variability and enhances baro-receptor reflex sensitivity in spontaneously hypertensive rats. Int J Radiat Biol. 2017;93:527–34.28051886 10.1080/09553002.2017.1276307
28. Japundzic-Zigon N Physiological mechanisms in regulation of blood pressure fast frequency variations Clin Exp Hypertens 1998 20 359 88 10.3109/10641969809053219 9607401
Japundzic-Zigon N. Physiological mechanisms in regulation of blood pressure fast frequency variations. Clin Exp Hypertens. 1998;20:359–88.9607401 10.3109/10641969809053219
29. Laude D Elghozi JL Girard A Bellard E Bouhaddi M Castiglioni P Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study) Am J Physiol Regul Integr Comp Physiol 2004 286 R226 31 10.1152/ajpregu.00709.2002 14500269
Laude D, Elghozi JL, Girard A, Bellard E, Bouhaddi M, Castiglioni P, et al. Comparison of various techniques used to estimate spontaneous baroreflex sensitivity (the EuroBaVar study). Am J Physiol Regul Integr Comp Physiol. 2004;286:R226–31.14500269 10.1152/ajpregu.00709.2002
30. Jovanovic S Skoric T Sarenac O Milutinovic-Smiljanic S Japundzic-Zigon N Bajic D Copula as a dynamic measure of cardiovascular signal interactions Biomed Signal Process Control 2018 43 250 64 10.1016/j.bspc.2018.03.007
Jovanovic S, Skoric T, Sarenac O, Milutinovic-Smiljanic S, Japundzic-Zigon N, Bajic D. Copula as a dynamic measure of cardiovascular signal interactions. Biomed Signal Process Control. 2018;43:250–64.10.1016/j.bspc.2018.03.007
31. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 2001 25 402 8 10.1006/meth.2001.1262 11846609
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.11846609 10.1006/meth.2001.1262
32. Son SJ Filosa JA Potapenko ES Biancardi VC Zheng H Patel KP Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks Neuron 2013 78 1036 49 10.1016/j.neuron.2013.04.025 23791197
Son SJ, Filosa JA, Potapenko ES, Biancardi VC, Zheng H, Patel KP, et al. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron. 2013;78:1036–49.23791197 10.1016/j.neuron.2013.04.025
33. Hurbin A Dubrez L Coll JL Favrot MC Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines J Biol Chem 2002 277 49127 33 10.1074/jbc.M207584200 12356750
Hurbin A, Dubrez L, Coll JL, Favrot MC. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. J Biol Chem. 2002;277:49127–33.12356750 10.1074/jbc.M207584200
34. Zemo DA McCabe JT Salt-loading increases vasopressin and vasopressin 1b receptor mRNA in the hypothalamus and choroid plexus Neuropeptides 2001 35 181 8 10.1054/npep.2001.0864 11884209
Zemo DA, McCabe JT. Salt-loading increases vasopressin and vasopressin 1b receptor mRNA in the hypothalamus and choroid plexus. Neuropeptides. 2001;35:181–8.11884209 10.1054/npep.2001.0864
35. Lang RE Ganten D Ganten U Rascher W Unger T Pathogenesis of hypertension in spontaneously hypertensive rats: definite evidence against a pressor role of vasopressin Clin Exp Hypertens A 1984 6 121 38 6697549
Lang RE, Ganten D, Ganten U, Rascher W, Unger T. Pathogenesis of hypertension in spontaneously hypertensive rats: definite evidence against a pressor role of vasopressin. Clin Exp Hypertens A. 1984;6:121–38.6697549
36. Johnston CI Vasopressin in circulatory control and hypertension J Hypertens 1985 3 557 69 10.1097/00004872-198512000-00001 2935570
Johnston CI. Vasopressin in circulatory control and hypertension. J Hypertens. 1985;3:557–69.2935570 10.1097/00004872-198512000-00001
37. Crofton JT Share L Shade RE Allen C Tarnowski D Vasopressin in the rat with spontaneous hypertension [Internet] Am J Physiol-Heart Circ Physiol 1978 235 H361 6 10.1152/ajpheart.1978.235.4.H361
Crofton JT, Share L, Shade RE, Allen C, Tarnowski D. Vasopressin in the rat with spontaneous hypertension [Internet]. Am J Physiol-Heart Circ Physiol. 1978;235:H361–6.10.1152/ajpheart.1978.235.4.H361
38. Mohring J Kintz J Schoun J Robert McNeill J Pressor responsiveness and cardiovascular reflex activity in spontaneously hypertensive and normotensive rats during vasopressin infusion [Internet] J Cardiovasc Pharmacol 1981 3 948 57 10.1097/00005344-198109000-00004 6168862
Mohring J, Kintz J, Schoun J, Robert McNeill J. Pressor responsiveness and cardiovascular reflex activity in spontaneously hypertensive and normotensive rats during vasopressin infusion [Internet]. J Cardiovasc Pharmacol. 1981;3:948–57.6168862 10.1097/00005344-198109000-00004
39. Yi SS Kim HJ Do SG Lee YB Ahn HJ Hwang IK Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats Anat Cell Biol 2012 45 114 20 10.5115/acb.2012.45.2.114 22822466
Yi SS, Kim HJ, Do SG, Lee YB, Ahn HJ, Hwang IK, et al. Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats. Anat Cell Biol. 2012;45:114–20.22822466 10.5115/acb.2012.45.2.114
40. Savić B Martin A Mecawi AS Bukumirić Z Antunes-Rodrigues J Murphy D Vasopressin and v1br gene expression is increased in the hypothalamic PVN of borderline hypertensive rats Hypertens Res 2020 43 1165 74 10.1038/s41440-020-0469-2 32415179
Savić B, Martin A, Mecawi AS, Bukumirić Z, Antunes-Rodrigues J, Murphy D, et al. Vasopressin and v1br gene expression is increased in the hypothalamic PVN of borderline hypertensive rats. Hypertens Res. 2020;43:1165–74.32415179 10.1038/s41440-020-0469-2
41. Rascher W Weidmann E Gross F Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats Clin Sci 1981 61 295 8 10.1042/cs0610295
Rascher W, Weidmann E, Gross F. Vasopressin in the plasma of stroke-prone spontaneously hypertensive rats. Clin Sci. 1981;61:295–8.10.1042/cs0610295
42. Davison JM Sheills EA Barron WM Robinson AG Lindheimer MD Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy J Clin Invest 1989 83 1313 8 10.1172/JCI114017 2703533
Davison JM, Sheills EA, Barron WM, Robinson AG, Lindheimer MD. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy. J Clin Invest. 1989;83:1313–8.2703533 10.1172/JCI114017
43. Rosenbloom AA Sack J Fisher DA The circulating vasopressinase of pregnancy: species comparison with radioimmunoassay Am J Obstet Gynecol 1975 121 316 20 10.1016/0002-9378(75)90005-8 1115145
Rosenbloom AA, Sack J, Fisher DA. The circulating vasopressinase of pregnancy: species comparison with radioimmunoassay. Am J Obstet Gynecol. 1975;121:316–20.1115145 10.1016/0002-9378(75)90005-8
44. Ohara M Martin PY Xu DL St John J Pattison TA Kim JK Upregulation of aquaporin 2 water channel expression in pregnant rats J Clin Invest 1998 101 1076 83 10.1172/JCI649 9486978
Ohara M, Martin PY, Xu DL, St John J, Pattison TA, Kim JK, et al. Upregulation of aquaporin 2 water channel expression in pregnant rats. J Clin Invest. 1998;101:1076–83.9486978 10.1172/JCI649
45. Parry LJ Poterski RS Summerlee AJ Effects of relaxin on blood pressure and the release of vasopressin and oxytocin in anesthetized rats during pregnancy and lactation Biol Reprod 1994 50 622 8 10.1095/biolreprod50.3.622 8167234
Parry LJ, Poterski RS, Summerlee AJ. Effects of relaxin on blood pressure and the release of vasopressin and oxytocin in anesthetized rats during pregnancy and lactation. Biol Reprod. 1994;50:622–8.8167234 10.1095/biolreprod50.3.622
46. Pyner S Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation J Chem Neuroanat 2009 38 197 208 10.1016/j.jchemneu.2009.03.005 19778682
Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanat. 2009;38:197–208.19778682 10.1016/j.jchemneu.2009.03.005
47. Szczepanska-Sadowska E Cudnoch-Jedrzejewska A Wsol A The role of oxytocin and vasopressin in the pathophysiology of heart failure in pregnancy and in fetal and neonatal life Am J Physiol Heart Circ Physiol 2020 318 H639 51 10.1152/ajpheart.00484.2019 32056469
Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Wsol A. The role of oxytocin and vasopressin in the pathophysiology of heart failure in pregnancy and in fetal and neonatal life. Am J Physiol Heart Circ Physiol. 2020;318:H639–51.32056469 10.1152/ajpheart.00484.2019
48. Nunn N Womack M Dart C Barrett-Jolley R Function and pharmacology of spinally-projecting sympathetic pre-autonomic neurones in the paraventricular nucleus of the hypothalamus Curr Neuropharmacol 2011 9 262 77 10.2174/157015911795596531 22131936
Nunn N, Womack M, Dart C, Barrett-Jolley R. Function and pharmacology of spinally-projecting sympathetic pre-autonomic neurones in the paraventricular nucleus of the hypothalamus. Curr Neuropharmacol. 2011;9:262–77.22131936 10.2174/157015911795596531
49. Horn T Smith PM McLaughlin BE Bauce L Marks GS Pittman QJ Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications Am J Physiol 1994 266 R306 13 8304554
Horn T, Smith PM, McLaughlin BE, Bauce L, Marks GS, Pittman QJ, et al. Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am J Physiol. 1994;266:R306–13.8304554
50. Li Y Zhang W Stern JE Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA Neuroscience 2003 118 585 601 10.1016/S0306-4522(03)00042-3 12710969
Li Y, Zhang W, Stern JE. Nitric oxide inhibits the firing activity of hypothalamic paraventricular neurons that innervate the medulla oblongata: role of GABA. Neuroscience. 2003;118:585–601.12710969 10.1016/S0306-4522(03)00042-3
51. Stern JE Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration? Prog Biophys Mol Biol 2004 84 197 215 10.1016/j.pbiomolbio.2003.11.015 14769436
Stern JE. Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration? Prog Biophys Mol Biol. 2004;84:197–215.14769436 10.1016/j.pbiomolbio.2003.11.015
52. Li DP Pan HL Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension Hypertension 2007 49 916 25 10.1161/01.HYP.0000259666.99449.74 17309953
Li DP, Pan HL. Glutamatergic inputs in the hypothalamic paraventricular nucleus maintain sympathetic vasomotor tone in hypertension. Hypertension. 2007;49:916–25.17309953 10.1161/01.HYP.0000259666.99449.74
53. Okere CO Higuchi T Down-regulation of endogenous nitric oxide synthase in late-pregnancy and parturition in the rat hypothalamic magnocellular neurons and neurohypophysis Neurosci Lett 1996 220 133 6 10.1016/S0304-3940(96)13248-1 8981491
Okere CO, Higuchi T. Down-regulation of endogenous nitric oxide synthase in late-pregnancy and parturition in the rat hypothalamic magnocellular neurons and neurohypophysis. Neurosci Lett. 1996;220:133–6.8981491 10.1016/S0304-3940(96)13248-1
54. Vaccari C Lolait SJ Ostrowski NL Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain Endocrinology 1998 139 5015 33 10.1210/endo.139.12.6382 9832441
Vaccari C, Lolait SJ, Ostrowski NL. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology. 1998;139:5015–33.9832441 10.1210/endo.139.12.6382
55. Gouzènes L Desarménien MG Hussy N Richard P Moos FC Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons J Neurosci 1998 18 1879 85 10.1523/JNEUROSCI.18-05-01879.1998 9465012
Gouzènes L, Desarménien MG, Hussy N, Richard P, Moos FC. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci. 1998;18:1879–85.9465012 10.1523/JNEUROSCI.18-05-01879.1998
56. Engelmann M, Ebner K, Landgraf R, Holsboer F, Wotjak1 CT. Emotional stress triggers intrahypothalamic but not peripheral release of oxytocin in male rats. J Neuroendocrinol. 1999;11:867–72.
57. Landry M Vila-Porcile E Hökfelt T Calas A Differential routing of coexisting neuropeptides in vasopressin neurons Eur J Neurosci 2003 17 579 89 10.1046/j.1460-9568.2003.02472.x 12814355
Landry M, Vila-Porcile E, Hökfelt T, Calas A. Differential routing of coexisting neuropeptides in vasopressin neurons. Eur J Neurosci. 2003;17:579–89.12814355 10.1046/j.1460-9568.2003.02472.x
58. Ophir AG Sorochman G Evans BL Prounis GS Stability and dynamics of forebrain vasopressin receptor and oxytocin receptor during pregnancy in prairie voles J Neuroendocrinol 2013 25 719 28 10.1111/jne.12049 23656585
Ophir AG, Sorochman G, Evans BL, Prounis GS. Stability and dynamics of forebrain vasopressin receptor and oxytocin receptor during pregnancy in prairie voles. J Neuroendocrinol. 2013;25:719–28.23656585 10.1111/jne.12049
59. Caughey SD Klampfl SM Bishop VR Pfoertsch J Neumann ID Bosch OJ Changes in the intensity of maternal aggression and central oxytocin and vasopressin V1a receptors across the peripartum period in the rat J Neuroendocrinol 2011 23 1113 24 10.1111/j.1365-2826.2011.02224.x 21929717
Caughey SD, Klampfl SM, Bishop VR, Pfoertsch J, Neumann ID, Bosch OJ, et al. Changes in the intensity of maternal aggression and central oxytocin and vasopressin V1a receptors across the peripartum period in the rat. J Neuroendocrinol. 2011;23:1113–24.21929717 10.1111/j.1365-2826.2011.02224.x
60. Dayanithi G Sabatier N Widmer H Intracellular calcium signalling in magnocellular neurones of the rat supraoptic nucleus: understanding the autoregulatory mechanisms Exp Physiol 2000 85 75S 84S 10.1111/j.1469-445X.2000.tb00010.x 10795909
Dayanithi G, Sabatier N, Widmer H. Intracellular calcium signalling in magnocellular neurones of the rat supraoptic nucleus: understanding the autoregulatory mechanisms. Exp Physiol. 2000;85:75S–84S.10795909 10.1111/j.1469-445X.2000.tb00010.x
61. Slangen BF Out IC Janssen BJ Peeters LL Blood pressure and heart rate variability in early pregnancy in rats Am J Physiol 1997 273 H1794 9 9362245
Slangen BF, Out IC, Janssen BJ, Peeters LL. Blood pressure and heart rate variability in early pregnancy in rats. Am J Physiol. 1997;273:H1794–9.9362245
62. Natali LH Troiano JA Potje SR Dias DPM Antoniali C Pregnancy restores altered sympathetic vasomotor modulation and parasympathetic cardiac modulation in hypertensive rats Pregnancy Hypertens 2022 28 180 8 10.1016/j.preghy.2022.05.002 35569243
Natali LH, Troiano JA, Potje SR, Dias DPM, Antoniali C. Pregnancy restores altered sympathetic vasomotor modulation and parasympathetic cardiac modulation in hypertensive rats. Pregnancy Hypertens. 2022;28:180–8.35569243 10.1016/j.preghy.2022.05.002
63. Mishra JS Gopalakrishnan K Kumar S Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats Biol Reprod 2018 99 1091 9 10.1093/biolre/ioy130 29860295
Mishra JS, Gopalakrishnan K, Kumar S. Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats. Biol Reprod. 2018;99:1091–9.29860295 10.1093/biolre/ioy130
64. Steinback CD Fraser GM Usselman CW Reyes LM Julian CG Stickland MK Blunted sympathetic neurovascular transduction during normotensive pregnancy J Physiol 2019 597 3687 96 10.1113/JP277714 31106429
Steinback CD, Fraser GM, Usselman CW, Reyes LM, Julian CG, Stickland MK, et al. Blunted sympathetic neurovascular transduction during normotensive pregnancy. J Physiol. 2019;597:3687–96.31106429 10.1113/JP277714
65. Paller MS Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats Am J Physiol 1984 247 H100 8 6377924
Paller MS. Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats. Am J Physiol. 1984;247:H100–8.6377924
66. Gant NF Daley GL Chand S Whalley PJ MacDonald PC A study of angiotensin II pressor response throughout primigravid pregnancy J Clin Invest 1973 52 2682 9 10.1172/JCI107462 4355997
Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52:2682–9.4355997 10.1172/JCI107462
67. Nisell H Hjemdahl P Linde B Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension Clin Physiol 1985 5 479 93 10.1111/j.1475-097X.1985.tb00779.x 4053528
Nisell H, Hjemdahl P, Linde B. Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. Clin Physiol. 1985;5:479–93.4053528 10.1111/j.1475-097X.1985.tb00779.x
68. Japundzic N Grichois ML Zitoun P Laude D Elghozi JL Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers J Auton Nerv Syst 1990 30 91 100 10.1016/0165-1838(90)90132-3 1973426
Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Auton Nerv Syst. 1990;30:91–100.1973426 10.1016/0165-1838(90)90132-3
69. Laude D Weise F Girard A Elghozi JL Spectral analysis of systolic blood pressure and heart rate oscillations related to respiration Clin Exp Pharm Physiol 1995 22 352 7 10.1111/j.1440-1681.1995.tb02014.x
Laude D, Weise F, Girard A, Elghozi JL. Spectral analysis of systolic blood pressure and heart rate oscillations related to respiration. Clin Exp Pharm Physiol. 1995;22:352–7.10.1111/j.1440-1681.1995.tb02014.x
70. Brack KE Winter J Ng GA Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation–tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure Heart Fail Rev 2013 18 389 408 10.1007/s10741-012-9314-2 22678767
Brack KE, Winter J, Ng GA. Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation–tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure. Heart Fail Rev. 2013;18:389–408.22678767 10.1007/s10741-012-9314-2
71. Paton JFR Boscan P Pickering AE Nalivaiko E The yin and yang of cardiac autonomic control: vago-sympathetic interactions revisited Brain Res Brain Res Rev 2005 49 555 65 10.1016/j.brainresrev.2005.02.005 16269319
Paton JFR, Boscan P, Pickering AE, Nalivaiko E. The yin and yang of cardiac autonomic control: vago-sympathetic interactions revisited. Brain Res Brain Res Rev. 2005;49:555–65.16269319 10.1016/j.brainresrev.2005.02.005
72. Milutinović S Murphy D Japundzić-Zigon N The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study Am J Physiol Regul Integr Comp Physiol 2006 291 R1579 91 10.1152/ajpregu.00764.2005 17085750
Milutinović S, Murphy D, Japundzić-Zigon N. The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1579–91.17085750 10.1152/ajpregu.00764.2005
73. Baumert M Walther T Baier V Stepan H Faber R Voss A [Heart rate and blood pressure interaction in normotensive and chronic hypertensive pregnancy] Biomed Tech 2002 47 554 6 10.1515/bmte.2002.47.s1b.554
Baumert M, Walther T, Baier V, Stepan H, Faber R, Voss A. [Heart rate and blood pressure interaction in normotensive and chronic hypertensive pregnancy]. Biomed Tech. 2002;47:554–6.10.1515/bmte.2002.47.s1b.554
74. Faber R Baumert M Stepan H Wessel N Voss A Walther T Baroreflex sensitivity, heart rate, and blood pressure variability in hypertensive pregnancy disorders J Hum Hypertens 2004 18 707 12 10.1038/sj.jhh.1001730 15116143
Faber R, Baumert M, Stepan H, Wessel N, Voss A, Walther T. Baroreflex sensitivity, heart rate, and blood pressure variability in hypertensive pregnancy disorders. J Hum Hypertens. 2004;18:707–12.15116143 10.1038/sj.jhh.1001730
75. Tita AT Szychowski JM Boggess K Dugoff L Sibai B Lawrence K Treatment for mild chronic hypertension during pregnancy N Engl J Med 2022 386 1781 92 10.1056/NEJMoa2201295 35363951
Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386:1781–92.35363951 10.1056/NEJMoa2201295
